FDA finalizes cell and gene therapy potency guidance
The guidance gives developers a standardized framework for potency assays, a long-running bottleneck in CGT approvals.
Read at RAPS →Full coverage · 10 outlets
- RAPS · lead
- OncodailyFDA Issues New Guidance on Cell and Gene Therapy Potency
- Voice of HealthcareUS FDA Issues Final Guidance to Strengthen Cell and Gene Therapy Quality Standards
- The Pharma LetterFDA provides guidance for cell and gene therapy development
- BioSpacePlug-and-play gene therapy: FDA executes on vision that’s been in the works for years
- Targeted OncologyFDA Finalizes Potency Guidance for Cell and Gene Therapy Products
- BioPharm InternationalFDA Finalizes Potency Assurance Guidance for Cell and Gene Therapies
- AllSciFDA finalizes risk-based potency strategy guidance for cell and gene therapy products
- CGTLive®FDA Finalizes Sets of Guidelines for Both CAR-T Products and Genome Editing Products
- TargetedoncFDA Finalizes Potency Guidance for Cell and Gene Therapy Products